Borrelia burgdorferi specific serum and cerebrospinal fluid antibodies in Lyme neuroborreliosis
Open Access
- 22 July 2022
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 104 (3) , 115782
Abstract
No abstract availableKeywords
Funding Information
- Turun Yliopistollinen Keskussairaala
- Suomen Lääketieteen Säätiö
- Orionin Tutkimussäätiö
- TYKS Foundation
This publication has 17 references indexed in Scilit:
- Lyme borreliosisNature Reviews Disease Primers, 2016
- Course and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory FindingsClinical Infectious Diseases, 2016
- Development of a Metabolic Biosignature for Detection of Early Lyme DiseaseClinical Infectious Diseases, 2015
- Lyme borreliosisThe Lancet, 2012
- High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patientsClinical Microbiology and Infection, 2011
- EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosisEuropean Journal of Neurology, 2009
- Lyme borreliosis: a European perspective on diagnosis and clinical managementCurrent Opinion in Infectious Diseases, 2009
- Comparison of Findings for Patients with Borrelia garinii and Borrelia afzelii Isolated from Cerebrospinal FluidClinical Infectious Diseases, 2006
- Crystal Structure of Lyme Disease Variable Surface Antigen VlsE of Borrelia burgdorferiJournal of Biological Chemistry, 2002
- Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses toBorrelia burgdorferi10–20 Years after Active Lyme DiseaseClinical Infectious Diseases, 2001